BlueOcean Wins FDA 510(k) Clearance for Excelsior Fixation System
DENVER, COLORADO | January 26, 2026 — BlueOcean Global has received FDA 510(k) clearance for its Excelsior™ External Fixation...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
DENVER, COLORADO | January 26, 2026 — BlueOcean Global has received FDA 510(k) clearance for its Excelsior™ External Fixation...
TAMPERE, Finland — December 14, 2025 — Bioretec Ltd., a pioneer in fully biodegradable orthopedic implants, announced it has...
